FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Aurobindo Pharma Famotidine Tablets 40mg Recall

Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Ph…

Aurobindo Pharma USA Inc. · East Windsor, NJ

Risk level
Class II
Reported by FDA
Mar 10, 2021
Recall ID
D-0290-2021
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Famotidine Tablets 40mg starting Jan 20, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0290-2021 on Mar 10, 2021. Reason: Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg. Status: Terminated.

Why it was recalled

Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.

Product description

Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99

Lot numbers, UPCs & expiration codes

Lot #: P2000467, Exp 7/2022

Where it was sold

TX, CA, GA, PA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0290-2021
Classification
Class II
Status
Terminated
Recall initiated
Jan 20, 2021
FDA report date
Mar 10, 2021
Quantity
1296 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc.

Original FDA data

Every field from FDA enforcement report D-0290-2021, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
87193
Address
279 Princeton Hightstown Rd
Code information
Lot #: P2000467, Exp 7/2022
Postal code
08520-1401
Report date
Mar 10, 2021
Product type
Drugs
Recall number
D-0290-2021
Classification
Class II
Recalling firm
Aurobindo Pharma USA Inc.
Product quantity
1296 bottles
Termination date
Oct 12, 2023
Reason for recall
Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99
Distribution pattern
TX, CA, GA, PA
Recall initiation date
Jan 20, 2021
Initial firm notification
Letter
Center classification date
Feb 26, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0290-2021, published Mar 10, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls